Tumour budding is a novel marker in breast cancer: the clinical application and future prospects

KEY MESSAGES: Currently, tumour budding is a poor prognosis for various solid tumours, also in breast cancer. Tumour budding is based on epithelial-mesenchymal transition and tumour microenvironment factors and is presumed to be an early step in the metastatic process. Breast cancer tumour budding s...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ting, Bao, Hui, Meng, Yu-hua, Zhu, Jian-lin, Chu, Xiao-dong, Chu, Xiao-li, Pan, Jing-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103277/
https://www.ncbi.nlm.nih.gov/pubmed/35535687
http://dx.doi.org/10.1080/07853890.2022.2070272
_version_ 1784707521702789120
author Huang, Ting
Bao, Hui
Meng, Yu-hua
Zhu, Jian-lin
Chu, Xiao-dong
Chu, Xiao-li
Pan, Jing-hua
author_facet Huang, Ting
Bao, Hui
Meng, Yu-hua
Zhu, Jian-lin
Chu, Xiao-dong
Chu, Xiao-li
Pan, Jing-hua
author_sort Huang, Ting
collection PubMed
description KEY MESSAGES: Currently, tumour budding is a poor prognosis for various solid tumours, also in breast cancer. Tumour budding is based on epithelial-mesenchymal transition and tumour microenvironment factors and is presumed to be an early step in the metastatic process. Breast cancer tumour budding still needs multi-centre experiments. We summarize the current research on breast cancer tumour budding, analyse the method of discriminating breast cancer tumour budding and explore the prognostic role and mechanism in breast cancer.
format Online
Article
Text
id pubmed-9103277
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-91032772022-05-14 Tumour budding is a novel marker in breast cancer: the clinical application and future prospects Huang, Ting Bao, Hui Meng, Yu-hua Zhu, Jian-lin Chu, Xiao-dong Chu, Xiao-li Pan, Jing-hua Ann Med Oncology KEY MESSAGES: Currently, tumour budding is a poor prognosis for various solid tumours, also in breast cancer. Tumour budding is based on epithelial-mesenchymal transition and tumour microenvironment factors and is presumed to be an early step in the metastatic process. Breast cancer tumour budding still needs multi-centre experiments. We summarize the current research on breast cancer tumour budding, analyse the method of discriminating breast cancer tumour budding and explore the prognostic role and mechanism in breast cancer. Taylor & Francis 2022-05-10 /pmc/articles/PMC9103277/ /pubmed/35535687 http://dx.doi.org/10.1080/07853890.2022.2070272 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oncology
Huang, Ting
Bao, Hui
Meng, Yu-hua
Zhu, Jian-lin
Chu, Xiao-dong
Chu, Xiao-li
Pan, Jing-hua
Tumour budding is a novel marker in breast cancer: the clinical application and future prospects
title Tumour budding is a novel marker in breast cancer: the clinical application and future prospects
title_full Tumour budding is a novel marker in breast cancer: the clinical application and future prospects
title_fullStr Tumour budding is a novel marker in breast cancer: the clinical application and future prospects
title_full_unstemmed Tumour budding is a novel marker in breast cancer: the clinical application and future prospects
title_short Tumour budding is a novel marker in breast cancer: the clinical application and future prospects
title_sort tumour budding is a novel marker in breast cancer: the clinical application and future prospects
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103277/
https://www.ncbi.nlm.nih.gov/pubmed/35535687
http://dx.doi.org/10.1080/07853890.2022.2070272
work_keys_str_mv AT huangting tumourbuddingisanovelmarkerinbreastcancertheclinicalapplicationandfutureprospects
AT baohui tumourbuddingisanovelmarkerinbreastcancertheclinicalapplicationandfutureprospects
AT mengyuhua tumourbuddingisanovelmarkerinbreastcancertheclinicalapplicationandfutureprospects
AT zhujianlin tumourbuddingisanovelmarkerinbreastcancertheclinicalapplicationandfutureprospects
AT chuxiaodong tumourbuddingisanovelmarkerinbreastcancertheclinicalapplicationandfutureprospects
AT chuxiaoli tumourbuddingisanovelmarkerinbreastcancertheclinicalapplicationandfutureprospects
AT panjinghua tumourbuddingisanovelmarkerinbreastcancertheclinicalapplicationandfutureprospects

Ejemplares similares